AAMDSIF sponsors live education events throughout the year. This includes satellite symposia at annual medical association meetings, as well as smaller live regional events where community-based health professionals can hear from leading experts. The International Bone Marrow Failure Disease Scientific Symposium is our biennial professional meeting held near Washington, DC.
Great Debates and Updates in Hematological Malignancies
March 6-7, 2020 | Los Angeles, CA
April 3-4, 2020 | Chicago, IL
May 1-2, 2020 | New York, NY
In this 2-day, debate-style series, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology. Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.
Use code ENDORSER for $50 off registration
https://hematologicmalignancies.oncnet.com/
Bone Marrow Failure and Myeloid Neoplasm Symposium:
Advances in Diagnosis and Treatment
Saturday, April 25, 2020 | 8:00am
Georgia State University | Atlanta, GA
In joint sponsorship with the Georgia Cancer Center, Northside Hospital, and Emory Winship Cancer Center, the AAMDSIF Bone Marrow Failure and Myeloid Neoplasia Symposium will provide updates on the most recent research related to the biology, diagnosis and clinical management of bone marrow failure diseases, including myelodysplastic syndromes (MDS), aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH), acute myeloid leukemia (AML) and myeloproliferative neoplasms (MPN). The overall goal of this accredited continuing education symposium is to facilitate the translation of research findings into clinical practice and to improve the care of these patient populations.
Registration coming soon!
2020 ONS Congress Satellite Symposium
Emerging Therapies and Management Strategies of MDS and Myeloid Malignancies
Thursday, April 30, 2020 | 6:00am - 7:30am
Marriott River Center | Ballroom C, D, E
San Antonio, TX
The symposium will be presented at the ONS Annual Congress in San Antonio, TX in April 2020 and targeted to clinical nursing professionals in oncology. Case studies will be used to illustrate treatment decision-making and therapeutic challenges.
Topics will include:
- Latest developments in emerging treatment options for low-risk MDS, high-risk MDS, and secondary AML;
- Management strategies for chronic anemia side effects and treatment adherence;
- Psychosocial considerations and palliative care to improve the quality of life for this patient population
Seventh International Bone Marrow Failure Scientific Symposium
Collaborating to Transform Treatment and Improve Outcomes
July 16th and 17th | Bethesda North Marriott Hotel and Conference Center, Bethesda, MD
An Intensive Two-Day Conference Convening International Experts at the Forefront of Research and Treatment of Bone Marrow Failure DiseaseThis symposium will bring together physicians treating these diseases and laboratory researchers studying the immunology and cell biology of bone marrow failure disease to:
- Discuss current areas of controversy
- Share recent research results
- Propose specific recommendations for the highest priority directions for basic and clinical research needed to advance the field of research
Once thought of as distinct, aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) are now believed to be linked by similar pathophysiologic pathways.
With exciting new developments in the treatment of these diseases and new insights into the molecular pathogenesis of the diseases, AAMDSIF is coordinating this symposium to explore opportunities for collaborative research.
The symposium program has been designed to address the most up-to-date issues in each topic area and to encourage participant interaction. Each session includes presentations
by experts in the field followed by open discussion.
Poster session and networking opportunities are included in the program.
Limited travel support is available for new investigators. For more information, contact Alice Houk at (301) 279-7202 x101.
Registration coming soon!
Myelodysplastic Syndromes Transitioning to Acute Myeloid Leukemia
Thursday, January 23, 2020 | 1:00 pm ET
Register now for this comprehensive update on caring for patients with high-risk MDS and secondary AML
At the conclusion of this program, participants will be able to:
- Describe a management strategy for high-risk MDS/AML based on the clinical presentation, diagnostic workup and recent research findings
- Explain the role of genetic testing in risk assessment and stratification for this patient population
- Identify emerging treatment options for high-risk MDS and secondary AML
- Discuss the roles of a multidisciplinary health care team in addressing treatment goals and providing patient education to improve outcomes, including guiding patients and caregivers in decision making, financial issues, and palliative care options
- Identify resources for support and education for patients